NCI-designated Consortium Cancer Center
|
|
|
WEEKLY RESEARCH NEWSLETTER
|
|
|
Cancer Therapeutics Training (CT2) Program at the Moores UCSD Cancer Center -OPEN POSITIONS AVAILABLE
PIs: Dr. Michael Bouvet and Dr. Dwayne Stupack
Description: The goal of the Cancer Therapeutics Training (CT2) Program is to train the next generation of leaders in the field of cancer drug and diagnostics development. The CT2 Program is open to both MDs and PhDs and provides an intensive two-year period of research and training in the development of novel cancer therapeutics or diagnostics at the UCSD Moores Cancer Center. Trainees execute a research program under the direction of a member of the faculty of this Comprehensive Cancer Center while also participating in coursework, seminars, and lectures. The focus of the research may be basic, translational or clinical, but all trainees will become versed in each major phase of the drug development process. Graduates of the program are prepared to transition into leadership roles in cancer therapeutics development in either an academic or industrial environment.
Salary/Stipend Information: NIH stipend scale
Application Procedure:
- See website for more details about CT2 program: WEBSITE
-
Complete CT2 program application (form available to download from the website above)
- Curriculum Vitae
- A one-page personal statement
- Proof of U.S. Citizenship/Residency
-
Three letters of recommendation (one from an identified mentor)
- Skills and Knowledge Required: PhD or MD degree, US Citizen or permanent resident status
For more information or to apply, please contact:
Amy Spilkin, Ph.D.
|
Nominate an Emerging Leader in IO
SITC is pleased to announce the call for nominations for the 2022 Steven A. Rosenberg Scholars Award, one of the society's most prestigious opportunities for early career scientists.
The society is seeking the best and brightest to continue Dr. Rosenberg’s legacy with a research award for early career scientists focused on tackling challenges that face the field of cancer immunotherapy. Nominations are due July 15, 2022 and will be accepted via email to development@sitcancer.org.
|
SITC Wants Your Cutting-Edge Research
Submit your research for presentation at SITC 2022. SITC is looking to showcase your new, hot data at the meeting. Poster presentations and over 80 oral presentation opportunities are available. SITC will offer 37 Young Investigator Awards, all recognizing excellence in novel research and providing young investigators with the experience necessary for successful careers.
Submit your abstract now.
Important Dates
Now Open: Regular abstracts, Young Investigator Award abstracts and Late-Breaking abstract applications submission site opens
July 28, 2022: Regular abstracts, Young Investigator Award abstracts and Late-Breaking abstract applications submission site closes at 5 p.m. PDT
August 18, 2022: Late-Breaking abstracts submission site opens
August 30, 2022: Late-Breaking abstracts submission site closes at 5 p.m. PDT
For the full list of important abstract dates, information on abstract categories, guidelines and procedures, FAQs, or to submit your abstract, please visit sitcancer.org.
|
|
|
June 7, 2022
10:00 a.m.
UC San Diego Moores Cancer Center Distinguished Scientist Seminar Series
“Beyond Neurotransmission: Role of Acetylcholine in
Immune Regulation”
Location: Moores Cancer Center, Comer Commons, 2nd floor
Speaker: Tak Wah Mak, Ph.D.
Professor, Departments of Medical Biophysics and Immunology, University of Toronto
Director, Advanced Medical Discovery Institute, University Health Network, Toronto
OPTIONAL WEBINAR REGISTRATION
|
June 8, 2022
12:00 p.m.
Cancer Control Program Work in Progress Seminar Meeting Series
"The role of multi-level factors on psychosocial wellbeing and healthcare interactions among Childhood, Adolescent, and Young Adult cancer survivor"
Hosted by: Program Leaders Dr. Samir Gupta & Dr. Noe Crespo
Presented by: Carol Ochoa, Ph.D.
ZOOM MEETING LINK
|
June 8, 2022
4:30 p.m. - 5:30 p.m.
CCSG Solid Tumor Therapeutics Seminar
"Precision Medicine Strategies in Prostate Cancer"
Rana R. McKay, M.D.
Medical Oncologist
Associate Professor of Medicine, UC San Diego
ZOOM MEETING LINK
|
June 8, 2022
12:00 p.m. - 1:00 p.m.
CCSG Structural and Functional Genomics Cross Laboratory Meeting
"Fungi in the Cancer Microbiome"
Rob Knight, Ph.D.
Professor, Departments of Pediatrics, Bioengineering, and Computer Science & Engineering
Director, Center for Microbiome Innovation, UC San Diego
ZOOM MEETING LINK
|
June 13, 2022
11:00 a.m.
On behalf of Willis Li, Ph.D. (CBS program member)
“Stem Cells: Tales of Two Niches and Intrinsic Control”
Ting Xie, Ph.D.
Kerry Holdings Professor of Science
Chair Professor, Head Division of Life Science
Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR
Location: Upper Auditorium, MET
ZOOM MEETING LINK
|
June 22, 2022
12:00 p.m. - 1:00 p.m.
CCSG Structural and Functional Genomics Cross Laboratory Meeting
Shailja C. Shah, M.D., MPH
Division of Gastroenterology, UC San Diego
Staff Physician, GI Section, VA San Diego Healthcare System
|
|
|
Training & Education (CRTEC)
|
|
|
June 9, 2022
12:00 p.m. - 1:00 p.m.
Mentors:
Jill Mesirov, Ph.D.
Associate Vice Chancellor for Computational Health Sciences & Professor, Medicine, UC San Diego
Ferhat Ay, Ph.D.
Associate Professor
Computational Biology
La Jolla Institute for Immunology
Carrie House, Ph.D.
Assistant Professor, Department of Biology, Shiley Bioscience Center, San Diego State University
REGISTER HERE
Contact: For more information, contact Amy Spilkin, Ph.D.
|
|
|
ACS Funding Opportunities
|
|
|
Research Priority Area: Screening
Purpose: Detecting cancer early saves lives. Unfortunately, the important benefits of cancer screening are not reaching enough people. The purpose of this RFA is to fund innovative research that will facilitate more widespread cancer screening and early detection culminating in reduced cancer mortality.
Interdisciplinary Team Award: Funds team science to advance cancer screening and early detection. All Team Award applications must clearly articulate how the team will synergize to accelerate scientific advancement and clinical benefit.
LOI due to ACS on June 15, 2022. The award is for a 5-year term with $1.2M total costs ($200K a year, plus 20% allowable indirect costs). Application deadline if invited by ACS to apply, August 1, 2022
Research Scholar Grant: Up to 4 years, 165K/year
Application deadline: October 15, 2022
Clinician-Scientist Development Grant: 3-5 years, 135K/year
Application deadline: October 15, 2022
MORE INFO
|
|
|
NIH Funding Opportunities
|
|
|
MD22-008 Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional)
To support research that seeks to (1) understand the underlying mechanisms and (2) test interventions to address and mitigate the impact of health-related misinformation and disinformation on health disparities and the populations that experience health disparities.
$500k direct/yr for up to 5 yrs
Deadline: November 13, 2022
MORE INFO
|
CA22-015 Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional)
To provide resources to support the time and effort of transdisciplinary teams, in collaboration with institutions, clinics, and communities/tribes, to develop a cancer prevention and control research program and provide support to early-career investigators that focuses on and serves populations living in persistent poverty areas.
$1.5M direct/yr for up to 5 yrs.
Deadline: July 6, 2022
MORE INFO
|
Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54)
U54 The NIH, via support from the FDA Center for Tobacco Products (CTP), intends to fund 8 TCORS, corresponding to a total of $32 million, for fiscal year 2023. Future year amounts will depend on availability of funds.
Deadline: July 14, 2022
MORE INFO
|
CA22-017 Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)
To support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses.
Total $275,766 for Phase I awards, $1,838,436 for Phase II awards (NCI 2 yrs each)
Deadline: August 22, 2022
MORE INFO
|
Administrative Supplements to Support Cancer Disparity Collaborative Research
The purpose of this trans-NCI Funding Opportunity Announcement (FOA) is to promote new cancer disparities research among investigators who do not normally conduct it and to encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers. Cancer disparities research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental and population research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden and/or response to treatment in racial/ethnic minorities and/or underserved population groups.
$150,000 direct for 1 year
Deadline: September 6, 2022
|
Early-Stage/Advanced/Sustained Development of Informatics Technologies for Cancer Research and Management (R21/U01/U24 Clinical Trial Optional
Component of the NCI's Informatics Technology for Cancer Research (ITCR) Program; focuses on the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum.
$275k-unlimited direct costs 2-5 yrs, depending on mechanism
Deadline: November 17, 2022
|
|
|
Breast Cancer Research Program: Transformative Breast Cancer Consortium Award. The Transformative Breast Cancer Consortium Award is designed to support collaborations and ideas that will transform the lives of individuals with, and/or at risk for, breast cancer and will significantly accelerate progress toward ending breast cancer. Applicants must bring together different perspectives to develop new paradigms that will solve fundamental yet overarching problems in breast cancer.
Pre-Application Deadline: August 8, 2022
MORE INFO
|
Breast Cancer Research Program: Anticipated Funding Opportunities. These BCRP awards will support innovative, high-impact research, with a mission of ending breast cancer for Service Members, Veterans, and the general public. Funding mechanisms will include Breakthrough Awards, Era of Hope Scholar Awards, and Innovator Awards.
MORE INFO
|
|
|
June 8, 2022
9:00 a.m. - 12:00 p.m.
2022 CDOC Stakeholder Engagement Conferen: California’s Cancer Control Plan, COVID 19 Recovery, and Health Equity
Keynote Speakers: Rana McKay, M.D., and COE Community Advisory Board member, Dr. Daniel “Stony” Anderson
REGISTER HERE
|
June 23, 2022
10:00 a.m. - 12:00 p.m.
MCC’s Cancer Health Equity Collaborative (CHEC) meeting includes presentations from the California LGBTQ Health and Human Services Network on inclusive access to cancer care, Pfizer Oncology on diversity in clinical trials, as well as community partner updates.
If you’re interested in attending, please contact Valesca Largaespada.
|
|
|
New Developments in Precision Radiation Oncology & Radiogenomics Inaugural Symposium
June 16, 2022
8 a.m. - 6 p.m.
Keynote Speakers: Lawrence Marks, MD, UNC Chapel Hill and
Carmen Bergom, MD, PhD, Washington University School of Medicine in St. Louis
Location: The Alexandria at Torrey Pines Conference Center, La Jolla, CA
Organizers: Ida Deichaite, Ph.D., Vitali Moiseenko, Ph.D., Arno J. Mundt, M.D., FASTRO, FACRO, Kevin Moore, Ph.D., Xenia Ray, Ph.D., Moores Cancer Center & Radiation Medicine and Applied Sciences, UC San Diego
Contact: Ida Deichaite, Ph.D., ideichaite@ucsd.edu
REGISTER HERE
|
August 21, 2022
Luau & Legends of Surfing Invitational
|
October 11, 2022
UC San Diego Health Moores Cancer Center
Delivering Discoveries Annual Scientific Retreat
Location: Scripps Seaside Forum
8610 Kennel Way, La Jolla, CA 92037
Organizing Committee:
J. Silvio Gutkind Ph.D, Chair
Elena Martinez, Ph.D., Co-Chair
Ezra Cohen, M.D., Co-Chair
Seanne Falconer MBA, FACHE, Co-Chair
Mark Garcia, Co-Chair
|
October 20-21, 2022
Time: TBD
Sanford Stem Cell Annual Symposium co-hosted by Moores Cancer Center Hematologic Malignancies Program
Location: Sanford Consortium, Duane J. Roth Auditorium
2880 Torrey Pines Scenic Drive, La Jolla, CA 92037
The Sanford Stem Cell Symposium is a two-day multidisciplinary event highlighting recent breakthroughs in regenerative medicine. The program will highlight stem cell regeneration in several disease areas and interactive discussion panels regarding stem cells in space and stem cell clinical trials.
Hosted by:
Catriona Jamieson, MD, Ph.D., Deputy Director of Moores Cancer Center, Director of the Sanford Stem Cell Clinical Center and Chief of the Division of Regenerative Medicine, and Alysson Muotri, Ph.D., Co-Director, Stem Cell Program
Keynote speakers:
Derrick Rossi, Ph.D., Co-Founder, Moderna; Elizabeth Blackburn, Ph.D., Professor, UC San Francisco; and Thomas C. Sudhof, M.D., Professor, Stanford University
MORE INFO
|
October 25, 2022
Moores Cancer Center EAB Meeting
|
November 8-12, 2022
Join Us in Person at SITC 2022
37th Annual Meeting & Pre-Conference Programs
Location: Boston Convention and Exhibition Center, Boston, MA. Virtual participation also available at the same registration rates.
REGISTER TODAY!
|
January 28, 2022
Prostate Cancer Patient Summit
|
|
|
Newly opened clinical trials (May 2022)
DMT 6/1/2022
|
|
|
Research Administration Department at Moores Cancer Center Openings:
-
Research Grant Writer and Editor - #116068
-
Financial Analyst/Fund Manager - Pre-award req #116028
-
Financial Analyst/Fund Manager - Post-award req #115272
|
|
|
If you have newsworthy items to contribute, please contact our Marketing & Communications Manager, Renee Maude at amaude@health.ucsd.edu.
|
|
|
Moores Cancer Center is one of only 52 NCI-designated comprehensive cancer centers in the nation, and the only one providing multidisciplinary, research-driven detection, treatment, survivorship and prevention in the San Diego County region. The 360 member scientists and clinicians come from 22 UC San Diego specialty departments, Rady Children’s Hospital, San Diego State University and the La Jolla Institute of Immunology.
With strengths in stem cell research, immune-oncology, precision medicine, cancer disparities and pre-cancer and risk research, our researchers focus on translational oncology and drug development through partnerships with biotechnology and pharmaceutical companies. The Cancer Center was founded in 1978, the same year it received its NCI designation.
|
Research Administration Department
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
3855 Health Sciences Drive MC 0698 | La Jolla, CA 92093 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
|
|
|
|
